Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS) (GDC-0449)

This study has been completed.
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Children's Hospital & Research Center Oakland
ClinicalTrials.gov Identifier:
NCT00957229
First received: August 5, 2009
Last updated: June 2, 2016
Last verified: January 2016